Literature DB >> 20065862

Human peritoneal macrophages from ascitic fluid can be infected by a broad range of HIV-1 isolates.

Theresa L Chang1, Arielle Klepper, Jian Ding, John Garber, Aprille Rapista, Arevik Mosoian, Wolfgang Hubner, Julio Gutierrez, Jose Walewski, Jeffrey Abergel, Thomas Schiano, Andrea Branch.   

Abstract

Macrophages are major HIV target cells. They support both productive and latent HIV-1 infection. Susceptibility of primary macrophages to HIV depends on the anatomical location and activation state of the cells. We demonstrate that peritoneal macrophages (PMs) are abundant in ascitic fluid of patients with liver cirrhosis and are susceptible to HIV-1 infection. PMs expressed CD68, a differentiation marker, exhibited phagocytic activity, and survived in culture for 2 months without additional growth factors. Freshly isolated PMs were susceptible to HIV-1 R5 strains but not to X4-T-cell line-adapted strains. Interestingly, after 7 days in culture, PMs acquired susceptibility to X4-T-cell line-adapted strains. HIV entry inhibitors, TAK779 and AMD3100, blocked HIV infection of PMs, indicating that infection by R5 and X4 strains was mediated by CCR5 and CXCR4, respectively. Although PMs did not express detectable cell surface levels of CXCR4 and CCR5, they did express mRNAs of these HIV coreceptors and responded to stimulation by their natural ligands, SDF-1alpha and RANTES. PMs were susceptible to HIV-1 X4, R5, and X4R5 primary isolates. PMs after 7 days in culture produced greater amounts of X4 and X4R5 HIV than freshly isolated PMs. The day-7 PMs were more susceptible to R5 infection in a single-cycle infection assay, but there was no increase in viral production in a multiple-round infection assay. The level of CXCR4 mRNA and production of CC-chemokines (MIP-1alpha, MIP-1beta, and RANTES) increased significantly during 7 days in culture. Our results indicate that PMs are susceptible to receptor-mediated infection by a broad range of HIV strains. These primary macrophages could provide a valuable system for investigating the role of primary macrophages in HIV pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20065862      PMCID: PMC2840202          DOI: 10.1097/QAI.0b013e3181ca3401

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  48 in total

Review 1.  The role of monocytes and macrophages in the pathogenesis of HIV-1 infection.

Authors:  Katherine Kedzierska; Suzanne M Crowe
Journal:  Curr Med Chem       Date:  2002-11       Impact factor: 4.530

2.  Cofactors for human immunodeficiency virus entry into primary macrophages.

Authors:  R G Collman; Y Yi
Journal:  J Infect Dis       Date:  1999-05       Impact factor: 5.226

3.  Tissue-resident macrophages are productively infected ex vivo by primary X4 isolates of human immunodeficiency virus type 1.

Authors:  Prerana Jayakumar; Irina Berger; Frank Autschbach; Mark Weinstein; Benjamin Funke; Eric Verdin; Mark A Goldsmith; Oliver T Keppler
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

4.  Expression and use of human immunodeficiency virus type 1 coreceptors by human alveolar macrophages.

Authors:  S Worgall; R Connor; R J Kaner; E Fenamore; K Sheridan; R Singh; R G Crystal
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

5.  In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression.

Authors:  G Scarlatti; E Tresoldi; A Björndal; R Fredriksson; C Colognesi; H K Deng; M S Malnati; A Plebani; A G Siccardi; D R Littman; E M Fenyö; P Lusso
Journal:  Nat Med       Date:  1997-11       Impact factor: 53.440

6.  Regulation of human immunodeficiency virus type 1 infection, beta-chemokine production, and CCR5 expression in CD40L-stimulated macrophages: immune control of viral entry.

Authors:  R L Cotter; J Zheng; M Che; D Niemann; Y Liu; J He; E Thomas; H E Gendelman
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

7.  Exposure to bacterial products renders macrophages highly susceptible to T-tropic HIV-1.

Authors:  M Moriuchi; H Moriuchi; W Turner; A S Fauci
Journal:  J Clin Invest       Date:  1998-10-15       Impact factor: 14.808

8.  Infection of macrophages with lymphotropic human immunodeficiency virus type 1 can be arrested after viral DNA synthesis.

Authors:  Z B Huang; M J Potash; M Simm; M Shahabuddin; W Chao; H E Gendelman; E Eden; D J Volsky
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

9.  Human resident peritoneal macrophages: phenotype and biology.

Authors:  A Eischen; B Duclos; M Schmitt-Goguel; N Rouyer; J P Bergerat; M Hummel; R Oskam; F Oberling
Journal:  Br J Haematol       Date:  1994-12       Impact factor: 6.998

10.  Production of fibronectin by peritoneal macrophages and concentration of fibronectin in peritoneal fluid from patients with or without endometriosis.

Authors:  S Kauma; M R Clark; C White; J Halme
Journal:  Obstet Gynecol       Date:  1988-07       Impact factor: 7.661

View more
  3 in total

1.  Brain Microglial Cells Are Highly Susceptible to HIV-1 Infection and Spread.

Authors:  Jennifer J Cenker; Ryan D Stultz; David McDonald
Journal:  AIDS Res Hum Retroviruses       Date:  2017-06-26       Impact factor: 2.205

2.  HIV-1 induces telomerase activity in monocyte-derived macrophages, possibly safeguarding one of its reservoirs.

Authors:  Rita Reynoso; Matthias Wieser; Diego Ojeda; Maximilian Bönisch; Harald Kühnel; Federico Bolcic; Heribert Quendler; Johannes Grillari; Regina Grillari-Voglauer; Jorge Quarleri
Journal:  J Virol       Date:  2012-07-11       Impact factor: 5.103

3.  Functional Phenotypes of Peritoneal Macrophages Upon AMD3100 Treatment During Colitis-Associated Tumorigenesis.

Authors:  Shuai Wu; Weiwei Luo; Xing Wu; Zhaohua Shen; Xiaoyan Wang
Journal:  Front Med (Lausanne)       Date:  2022-05-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.